These outcomes, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the strategy of focusing on ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-associated Diseases. Conolidine statements being a innovative https://charlest738kbq3.targetblogs.com/profile